FdaApplication
BLA 761215
Identifiers
- fda_app_no: BLA761215
Properties
| Property | Value |
|---|---|
| applicant_name | Eli Lilly and Company |
| application_type | BLA |
| approval_date | 2021-12-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REZVOGLAR | INSULIN GLARGINE-AGLR | 300UNITS/3ML (100UNITS/ML) | Injection |
1 product